BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Renewed Information Letter on Erwinase® 10,000 IU/vial (crisantaspase): Shortage and instructions for use for the additional batch 177G*

Active substance: crisantaspase

The company Jazz Pharmaceuticals Germany GmbH is circulating information on use and handling instructions (visual inspection and filtering) of the Erwinase batch 177G* imported from the United Kingdom.

Download DHPC/Information letter , Download_VeroeffentlichtAm_EN PDF, 400KB, File does not meet accessibility standards